Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs

Transfusion Medicine Reviews

Volumn 18, Issue 4, 2004, Pages 245-256

  Garratty, George ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP ANTIBODY; BLOOD GROUP B ANTIGEN; GALACTOSIDASE; MACROGOL; SUGAR;

ALLOIMMUNIZATION; BIOSYNTHESIS; BLOOD CLOTTING; BLOOD DONOR; BLOOD GROUP A; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP O; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; BUDGET; CELL FUNCTION; CELL STRUCTURE; CELL SURVIVAL; COST BENEFIT ANALYSIS; CYTOCHEMISTRY; ERYTHROCYTE MEMBRANE; FOREIGN BODY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREACTIVITY; MASKING; MODULATION; MOLECULAR RECOGNITION; NONHUMAN; PHENOTYPE; RABBIT; RECIPIENT; REVIEW; SEROLOGY;

EID: 6344263851     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2004.06.005     Document Type: Article

References (60)

1. Morgan W.T.J. The human ABO blood group substances. Experientia. 3:1947;257
2. Watkins W.M. Changes in the specificity of blood group mucopolysaccharides induced by enzymes from Trichomonas foetus. Immunology. 5:1962;245-266
3. Iseki S. Glycosidases and serological changes in blood group substances. Aminoff D. Blood and Tissue Antigens. 1970;379-394 Academic Press, New York, NY
4. Kabat E.A. Blood Group Substances Their Chemistry and Immunochemistry. 1956;Academic Press, New York, NY
5. Morgan W.T.J., Watkins W.M. Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity. Glycoconj J. 17:2000;501-530
6. Watkins W.M. The ABO blood group system Historical background. Transfus Med. 11:2001;243-265
7. Lowe J.B. Carbohydrate-associated blood group antigens The ABO, H/Se, and Lewis loci. Garratty G. Immunobiology of Transfusion Medicine. 1994;3-36 Dekker, New York, NY
8. Zarnitz M.L., Kabat E.A. Immunochemical studies on blood groups. XXV. The action of coffe beans α-galactosidase on blood group B and BP1 substances. J Am Chem Soc. 82:1960;3953-3957
9. Yatziv S., Flowers H.M. Action of α-galactosidase on glycoprotein from human B-erythrocytes. Biochem Biophys Res Comm. 45:1971;514-518
10. Harpaz N., Flowers H.M., Sharon N. Studies on B-antigenic sites of human erythrocytes by use of coffee bean α-galactosidase. Arch Biochem Biophys. 170:1975;676-683
11. Lenny L., Goldstein J. Enzymatic removal of blood group B antigen from Gibbon erythrocytes. Transfusion. 20:1980;618. (abstr)
12. Goldstein J., Siviglia G., Hurst R., et al. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals. Science. 215:1982;168-170
13. Goldstein J. Conversion of ABO blood groups. Transfus Med Rev. III:1989;206-212
14. Lenny L.L., Hurst R., Goldstein J., et al. Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers. Blood. 77:1991;1383-1388
15. Lenny L.L., Hurst R., Goldstein J., et al. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O. Transfusion. 34:1994;209-214
16. Lenny L.L., Hurst R., Zhu A., et al. Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O Report on the end of Phase 1 trials. Transfusion. 35:1995;899-902
17. Kruskall M.S., AuBuchon J.P., Anthony K.Y., et al. Transfusion to blood group A and O patients of group B RBCs that have been converted to group O. Transfusion. 40:2000;1290-1298
18. 2 blood group specific glycoproteins. Eur J Biochem. 120:1981;243-249
19. Clausen H., Hakomori S. ABH and related histo-blood group antigens Immunochemical differences in carrier isotypes and their distribution. Vox Sang. 56:1989;1-20
20. 2 distinction. Proc Natl Acad Sci U S A. 82:1985;1199-1203
21. Clausen H., Levery S.B., Kannagi R., et al. Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization. J Biol Chem. 261:1986;1380-1387
22. Olsson M.L., Hill C.A., de la Vega H., et al. Universal red blood cells - Enzymatic conversion of blood group A and B antigens. Transfus Clin Biol. 22:2004;33-39
23. Olsson M.L. New developments in immunohematology. Vox Sang. 87:(suppl 2):2004;S66-S71
24. Kruskall M.S., AuBuchon J.P. Making Landsteiner's discovery superfluous Safety and economic implications of a universal group O red blood cell supply. Transfus Sci. 18:1997;613-620
25. Lublin D.M. Universal RBCs. Transfusion. 40:2000;1285-1289
26. Aubuchowski A., van Es T., Palczuk C., et al. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem. 252:1977;3578-3581
27. Aubuchowski A., McCoy J.R., Palczuk N.C., et al. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem. 252:1977;3582-3586
28. Jeong S.T., Byun S.M. The decrease of agglutinability of human AB type red blood cell by attachment of methoxy-polyethylene glycol. Art Cells Blood Subst Immob Biotech. 24:1996;358. (abstr)
29. Jeong S.T., Byun S.M. Decreased agglutinability of methoxy-polyethylene glycol attached red blood cells Significance as a blood substitute. Art Cells Blood Subs Immob Biotech. 24:1996;503-511
30. Hortin G.L., Lok H.T., Huang S.T. Progress toward preparation of universal donor red cells. Art Cells Blood Subst Immob Biotech. 24:1996;351. (abstr)
31. Hortin G.L., Huang S.T. Surface-pegylated red cells as potential universal donor red cells. Blood. 88:1996;181a(S1). (abstr)
32. Hortin G.L., Lok H.T., Huang S.T. Progress toward preparation of universal donor red cells. Art Cells Blood Subs Immob Biotech. 25:1997;487-491
33. Murad K., Koumpouras F., Talbot M., et al. Molecular camouflage of antigenic determinants on intact mammalian cells Possible applications to transfusion medicine. Blood. 88:1996;444a(S1). (abstr)
34. Scott M.D., Murad K.L., Mahany K.L., et al. Antigenic and immunogenic attenuation of erythrocytes by cell surface modification with methoxy (polyethylene glycol). Blood. 90:1997;436. (abstr)
35. Scott M.D., Murad K.L., Koumpouras F., et al. Chemical camouflage of antigenic determinants Stealth erythrocytes. Proc Natl Acad Sci U S A. 94:1997;7566-7571
36. Armstrong J.K., Meiselman H.J., Fisher T.C. Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low-shear viscosity. Am J Hematol. 56:1997;26-28
37. Fisher T.C., Armstrong J.K., Meiselman H.J., et al. Polyethylene glycol coating of red blood cells strongly inhibits agglutination but does not produce cells that are antigenically "silent" Transfusion. 37:1997;88S. (abstr)
38. Garratty G., Leger R., Arndt P., et al. Polyethylene glycol treatment can mask blood group antigens, but also cause non-specific protein uptake. Blood. 90:1997;473a. (abstr)
39. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Transfus Med Rev. IV:1990;297-312
40. Arndt P.A., Garratty G., Arndt P. Determining the clinical significance of blood group alloantibodies A reevaluation of the interpretation of monocyte monolayer assay results. Blood. 92:1998;563a. (abstr)
41. Garratty G. Stealth erythrocytes A possible transfusion product for the new century? Vox Sang. 78:(suppl 2):2000;143-147
42. Leger R.M., Arndt P., Garratty G. Normal donor sera can contain antibodies to polyethylene glycol. Transfusion. 41:2001;29S. (abstr)
43. Armstrong J.K., Leger R., Wenby R.B., et al. Occurrence of an antibody to poly(ethylene glycol) in normal donors. Blood. 102:2003;556a. (abstr)
44. Fisher T.C., Armstrong J.K., Wenby R.B., et al. Isolation and identification of a human antibody to poly(ethylene glycol). Blood. 102:2003;559a. (abstr)
45. Fisher T.C. PEG-coated red blood cells Simplifying blood transfusion in the new millennium? Immunohematology. 16:2000;37-48
46. Fisher T.C., Armstrong J.K., Meiselman H.J., et al. Second generation poly(ethylene glycol) surface coatings for red blood cells. Transfusion. 40:2000;119S. (abstr)
47. Huang S.T., Hortin G.L., Huang Z. Coating of red blood cells with crosslinked polyethylene glycol (XPEG) inhibits agglutination and shows favorable red cell survival. Transfusion. 38:1988;62S. (abstr)
48. Huang S.T., Huang Z., Marques M.B. Adding methoxy polyethylene glycol to red blood cells coated with crosslinked polyethylene glycol-albumin prevents reaction with naturally occurring antibodies while preserving red cell oxygen carrying capacity. Transfusion. 39:1999;80S. (abstr)
49. Armstrong J.K., Arndt P.A., Leger R.M., et al. Reduction of autologous IgG uptake by poly(ethylene glycol)-coated red blood cells. Transfusion. 40:2000;121S. (abstr)
50. Bradley A.J., Test S.T., Murad K.L., et al. Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs. Transfusion. 41:2001;1225-1233
51. Bradley A.J., Murad K.L., Regan K.L., et al. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes Size does matter. Biochimica et Biophysica Acta. 156:2002;147-158
52. Scott M.D., Murad K.L. Cellular camouflage Fooling the immune system with polymers. Curr Pharm Design. 4:1998;423-438
53. Murad K.L., Mahany K.L., Brugnara C., et al. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood. 93:1999;2121-2127
54. Scott M.D., Mahany K.L., Bradley A.J., et al. Size does matter Immunocamouflage of erythrocyte antigens by methoxypoly(ethylene glycol). Blood. 96:2000;64a. (abstr)
55. Scott M.D., Murad K.L. Reproducibility of red cell pegylation on the immunocamouflage of non-ABO antigens. Blood. 96:2000;110b. (abstr)
56. Garratty G. In vitro reactions with red blood cells that are not due to blood group antibodies A review. Immunohematology. 14:1998;1-11
57. Richter A.W., Åkerblom E. Polyethylene glycol reactive antibodies in man Titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors. Int Archs Allergy Appl Immun. 74:1984;36-39
58. Armstrong J.K., Wenby R.B., Meiselman J.H., et al. In vivo survival of poly(ethylene glycol)-coated red blood cells in the rabbit. Blood. 102:2003;94a. (abstr)
59. Linden J.V. Transfusion errors Causes and effects. Transfus Med Rev. 8:1994;169-183
60. Williamson L., Cohen H., Love E., et al. The serious hazards of transfusion (SHOT) initiative The UK approach to haemovigilance. Vox Sang. 78:(suppl 2):2000;291-295